Concepedia

Costs of Allogeneic Hematopoietic Stem Cell Transplantation

Britt‐Marie Svahn, O.O.A. Alvin, Olle Ringdén, Ann Gardulf, Mats Remberger

Transplantation · 2006 · 52 citations · 29 references

Abstract

Higher costs of ASCT were associated with retransplantation, acute leukemia, G-CSF prophylaxis, hospital care, myeloablative conditioning, and major transplant-related complications.

References

29

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

Shimon Slavin, Arnon Nagler, E Naparstek et al. · Blood · 1998 · 1.9K citations · Full text

Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

Shimon Slavin, Arnon Nagler, E Naparstek et al. · Blood · 1998 · 1.8K citations

One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation

Thomas Ed, CD Buckner, M Banaji et al. · Blood · 1977 · 955 citations · Full text

T-cell depletion of HLA-identical transplants in leukemia

A Marmont, MM Horowitz, Gale Rp et al. · Blood · 1991 · 741 citations · Full text

Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial

Rainer Storb, H. Joachim Deeg, M. S. Pepe et al. · Blood · 1989 · 431 citations · Full text